BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 16173960)

  • 1. Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network.
    Tiemann M; Schrader C; Klapper W; Dreyling MH; Campo E; Norton A; Berger F; Kluin P; Ott G; Pileri S; Pedrinis E; Feller AC; Merz H; Janssen D; Hansmann ML; Krieken H; Möller P; Stein H; Unterhalt M; Hiddemann W; Parwaresch R;
    Br J Haematol; 2005 Oct; 131(1):29-38. PubMed ID: 16173960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network.
    Hoster E; Rosenwald A; Berger F; Bernd HW; Hartmann S; Loddenkemper C; Barth TF; Brousse N; Pileri S; Rymkiewicz G; Kodet R; Stilgenbauer S; Forstpointner R; Thieblemont C; Hallek M; Coiffier B; Vehling-Kaiser U; Bouabdallah R; Kanz L; Pfreundschuh M; Schmidt C; Ribrag V; Hiddemann W; Unterhalt M; Kluin-Nelemans JC; Hermine O; Dreyling MH; Klapper W
    J Clin Oncol; 2016 Apr; 34(12):1386-94. PubMed ID: 26926679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blastoid and common variants of mantle cell lymphoma exhibit distinct immunophenotypic and interphase FISH features.
    Parrens M; Belaud-Rotureau MA; Fitoussi O; Carerre N; Bouabdallah K; Marit G; Dubus P; de Mascarel A; Merlio JP
    Histopathology; 2006 Mar; 48(4):353-62. PubMed ID: 16487357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2.
    Chuang SS; Huang WT; Hsieh PP; Tseng HH; Campo E; Colomer D; Ye H; Lu CL; Chang HM; Cho CY; Huang SH; Lu YC; Wu JD
    Pathol Int; 2006 Aug; 56(8):440-8. PubMed ID: 16872438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineation of distinct tumour profiles in mantle cell lymphoma by detailed cytogenetic, interphase genetic and morphological analysis.
    Katzenberger T; Kienle D; Stilgenbauer S; Höller S; Schilling C; Mäder U; Puppe B; Petzoldt C; Sander S; Bullinger L; Stöcklein H; Kalla J; Hartmann E; Adam P; Ott MM; Müller-Hermelink HK; Rosenwald A; Ott G
    Br J Haematol; 2008 Aug; 142(4):538-50. PubMed ID: 18564361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mantle cell lymphoma shows three morphological evolutions of classical, intermediate, and aggressive forms, which occur in parallel with increased labeling index of cyclin D1 and Ki-67.
    Kimura Y; Sato K; Arakawa F; Karube K; Nomura Y; Shimizu K; Aoki R; Hashikawa K; Yoshida S; Kiyasu J; Takeuchi M; Nino D; Sugita Y; Morito T; Yoshino T; Nakamura S; Kikuchi M; Ohshima K
    Cancer Sci; 2010 Mar; 101(3):806-14. PubMed ID: 20002441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative gene expression deregulation in mantle-cell lymphoma: correlation with clinical and biologic factors.
    Kienle D; Katzenberger T; Ott G; Saupe D; Benner A; Kohlhammer H; Barth TF; Höller S; Kalla J; Rosenwald A; Müller-Hermelink HK; Möller P; Lichter P; Döhner H; Stilgenbauer S
    J Clin Oncol; 2007 Jul; 25(19):2770-7. PubMed ID: 17563396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotypic variations in mantle cell lymphoma.
    Gao J; Peterson L; Nelson B; Goolsby C; Chen YH
    Am J Clin Pathol; 2009 Nov; 132(5):699-706. PubMed ID: 19846810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgV H mutations in blastoid mantle cell lymphoma characterize a subgroup with a tendency to more favourable clinical outcome.
    Cogliatti SB; Bertoni F; Zimmermann DR; Henz S; Diss TC; Ghielmini M; Schmid U
    J Pathol; 2005 Jul; 206(3):320-7. PubMed ID: 15887292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mantle cell lymphoma: prognostic capacity of the Follicular Lymphoma International Prognostic Index.
    Møller MB; Pedersen NT; Christensen BE
    Br J Haematol; 2006 Apr; 133(1):43-9. PubMed ID: 16512827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-gene model to predict survival in mantle-cell lymphoma using frozen or formalin-fixed, paraffin-embedded tissue.
    Hartmann E; Fernàndez V; Moreno V; Valls J; Hernández L; Bosch F; Abrisqueta P; Klapper W; Dreyling M; Hoster E; Müller-Hermelink HK; Ott G; Rosenwald A; Campo E
    J Clin Oncol; 2008 Oct; 26(30):4966-72. PubMed ID: 18606985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small cell variant of mantle cell lymphoma is an indolent lymphoma characterized by bone marrow involvement, splenomegaly, and a low Ki-67 index.
    Kimura Y; Sato K; Imamura Y; Arakawa F; Kiyasu J; Takeuchi M; Miyoshi H; Yoshida M; Niino D; Sugita Y; Morito T; Yoshino T; Nakamura S; Ohshima K
    Cancer Sci; 2011 Sep; 102(9):1734-41. PubMed ID: 21609366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability in morphology and cell proliferation in sequential biopsies of mantle cell lymphoma at diagnosis and relapse: clinical correlation and insights into disease progression.
    Vogt N; Klapper W
    Histopathology; 2013 Jan; 62(2):334-42. PubMed ID: 23240716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma.
    Espinet B; Salaverria I; Beà S; Ruiz-Xivillé N; Balagué O; Salido M; Costa D; Carreras J; Rodríguez-Vicente AE; Luís García J; Hernández-Rivas JM; Calasanz MJ; Siebert R; Ferrer A; Salar A; Carrió A; Polo N; García-Marco JA; Domingo A; González-Barca E; Romagosa V; Marugán I; López-Guillermo A; Millá F; Luís Mate J; Luño E; Sanzo C; Collado R; Oliver I; Monzó S; Palacín A; González T; Sant F; Salinas R; Ardanaz MT; Font L; Escoda L; Florensa L; Serrano S; Campo E; Solé F
    Genes Chromosomes Cancer; 2010 May; 49(5):439-51. PubMed ID: 20143418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma.
    Broyde A; Boycov O; Strenov Y; Okon E; Shpilberg O; Bairey O
    Am J Hematol; 2009 Jun; 84(6):338-43. PubMed ID: 19384938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score.
    Went P; Agostinelli C; Gallamini A; Piccaluga PP; Ascani S; Sabattini E; Bacci F; Falini B; Motta T; Paulli M; Artusi T; Piccioli M; Zinzani PL; Pileri SA
    J Clin Oncol; 2006 Jun; 24(16):2472-9. PubMed ID: 16636342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant ileocaecal serotonin-producing carcinoid tumours: the presence of a solid growth pattern and/or Ki67 index above 1% identifies patients with a poorer prognosis.
    Cunningham JL; Grimelius L; Sundin A; Agarwal S; Janson ET
    Acta Oncol; 2007; 46(6):747-56. PubMed ID: 17653896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of Ki-67 in mantle cell lymphoma is associated with de-regulation of several cell cycle regulatory components, as identified by global gene expression analysis.
    Ek S; Björck E; Porwit-MacDonald A; Nordenskjöld M; Borrebaeck CA
    Haematologica; 2004 Jun; 89(6):686-95. PubMed ID: 15194536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma.
    Joao C; Porrata LF; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Gastineau DA; Markovic SN
    Bone Marrow Transplant; 2006 May; 37(9):865-71. PubMed ID: 16532015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mantle cell lymphoma in the orbital and adnexal region.
    Rasmussen P; Sjö LD; Prause JU; Ralfkiaer E; Heegaard S
    Br J Ophthalmol; 2009 Aug; 93(8):1047-51. PubMed ID: 19429588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.